Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
J.P. Morgan event in focus amid biotech M&A, obesity frenzy Markets January 7, 2024 Lina Moiseienko/iStock Editorial by way of Getty Pictures The latest momentum in biotech deal-making, the rising curiosity in weight-loss medicine,…
Eli Lilly to add $4.1B U.S. sales from obesity drug Zepbound Markets November 12, 2023 hapabapa/iStock Editorial by way of Getty Photographs Gross sales from Eli Lilly’s (NYSE:LLY) newly permitted weight reduction treatment, Zepbound, may…
LLY NVO stocks in focus as Morgan Stanley projects over $50B obesity market (NYSE:LLY) Markets July 17, 2022 lucadp/iStock by way of Getty Photos Morgan Stanley says that world weight problems gross sales in 2030 might attain $54B,…
